Current treatments for AD recommended by the National Institute for Health and Care Excellence (NICE) include acetylcholinesterase inhibitors (AChEIs) prescribed individually to manage mild-to-moderate AD, and memantine, which is used in moderate-to-severe AD. Here, ACHE is linked to Alzheimer disease.